Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055726

10% owner sold 23,253 shares at an average $29.23 ($679,738)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-09 Sale : show line 1 in the form −13,727 $29.35 $402,887 7,674,449 D
2021-09-10 Sale : show line 2 in the form −5,931 $29.04 $172,236 7,668,518 D
2021-09-13 Sale : show line 3 in the form −3,595 $29.10 $104,615 7,664,923 D
Open-market sales · 23,253 sh · avg $29.23 · $679,738
Loading xslF345X03/doc4.xml…